|
Hot Stocks
| ShowHide Related Items >><< - 03/15/21
- Takeda, IDT support manufacturing of Johnson & Johnson's COVID-19 vaccine
- 03/12/21
- Johnson & Johnson says single-shot COVID vaccine granted EUL by WHO
- 03/11/21
- J&J COVID-19 vaccine granted conditional marketing authorization by EC
- 03/11/21
- EMA recommends conditional marketing authorization for Janssen COVID-19 vaccine
- 06:51 Today
- Eli Lilly announces mirikizumab met primary, secondary endpoints in LUCENT-1
- 03/15/21
- Eli Lilly falls -7.6%
- 03/14/21
- Fly Intel: Top five weekend stock stories
- 03/13/21
- Lilly says Alzheimer's trial first late-stage study to meet primary endpoint
- 08:14 Today
- Immutep enters second collaboration with Merck for Phase IIB trial in HNSCC
- 06:47 Today
- Merck receives FDA priority review for NDA for MK-6482
- 03/15/21
- Corcept Therapeutics initiates Phase 1b trial of Relacorilant plus Pembrolizumab
- 03/15/21
- Gilead, Merck confirm pact to co-develop long-acting treatments in HIV
- 03/11/21
- Evidence confirms high effectiveness of Pfizer, BioNTech COVID-19 vaccine
- 03/09/21
- Roche receives FDA approval of Ventana ALK CDx Assay
- 03/08/21
- NIH starts enrolling third trial of blood clotting treatments for COVID-19
- 03/03/21
- FDA expands approval of Pfizer's Lorbrena
- 07:18 Today
- Global Blood Therapeutics to in-license two SCD programs from Sanofi
- 03/15/21
- Regeneron, Sanofi announce Libtayo study to be stopped early due to OS benefit
- 03/12/21
- Sanofi, Translate Bio initiate SARS-CoV-2 vaccine candidate trial
- 03/04/21
- Regeneron, Sanofi announce FDA acceptance of Dupixent sBLA
- 06:46 Today
- AstraZeneca completes divestment of Viela shareholding
- 06:44 Today
- AstraZeneca to supply up to 500,000 additional doses of AZD7442 to U.S.
- 03/15/21
- Germany's health ministry suspends AstraZeneca vaccine use
- 03/14/21
- Fly Intel: Top five weekend stock stories
- 03/11/21
- Mersana Therapeutics appoints Allene Diaz to board of directors
- 03/11/21
- Vir, GSK Covid trial stopped after VIR-7831 shows 85% reduction in deaths
- 03/03/21
- Vir, GSK: DSMB recommends VIR-7831 arm of ACTIV-3 trial be closed to enrollment
- 03/02/21
- Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX
- 08:24 Today
- Pliant Therapeutics completes PLN-1474 Phase 1 study, transfer to Novartis
- 03/12/21
- NLS Pharmaceutics enters license agreement with Novartis for Sanorex
- 03/09/21
- Novartis reports CANOPY-2 trial did not meet primary endpoint
- 03/09/21
- Novartis, Molecular Partners announce initial results from ensovibep study
- 07:22 Today
- Roche launches SARS-CoV-2 variant test to help monitor emerging mutations
- 05:31 Today
- PTC Therapeutics announces two-year data from Part 2 of SUNFISH trial
- 03/15/21
- Roche to acquire GenMark Diagnostics for $24.05 per share in cash
- 03/12/21
- FDA sends alert on potential false positives with Roche Covid, flu test
- 03/12/21
- Aveo Pharmaceuticals partners with Bristol-Myers to evaluate Fotivda, Opdivo
- 03/08/21
- NIH starts enrolling third trial of blood clotting treatments for COVID-19
- 02/26/21
- Bristol-Myers receives positive CHMP opinion for Opdivo/Cabometyx combination
- 02/24/21
- Bluebird Bio, Bristol-Myers' KarMMa study meets primary endpoint, NEJM reports
- 02/10/21 BTIG
- Model N upgraded to Buy from Neutral at BTIG
- 02/01/21 SVB Leerink
- Moderna price target raised to $80 from $69 at SVB Leerink
- 02/01/21 Wells Fargo
- Moderna price target raised to $145 from $129 at Wells Fargo
- 02/01/21 BofA
- BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
- 07:05 Today Mizuho
- Mizuho sees 'good reasons to be optimistic' on Lilly's donanemab
- 03/15/21 JPMorgan
- Eli Lilly Alzheimer's data more mixed than expected, says JPMorgan
- 03/15/21 Truist
- Eli Lilly price target raised to $225 from $215 at Truist
- 03/15/21 Mizuho
- Lilly data not supportive of accelerated Alzheimer's approval, says Mizuho
- 03/15/21 Mizuho
- Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
- 03/15/21 Piper Sandler
- Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
- 02/25/21 SVB Leerink
- Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
- 02/25/21 Morgan Stanley
- Pandion downgraded to Equal Weight from Overweight at Morgan Stanley
- 02/23/21 B. Riley Securities
- B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
- 02/10/21 KeyBanc
- Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
- 02/04/21 DZ Bank
- Pfizer upgraded to Buy from Hold at DZ Bank
- 02/03/21 Mizuho
- Pfizer price target lowered to $42 from $44 at Mizuho
- 02/23/21 BofA
- BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
- 02/10/21 Morgan Stanley
- Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
- 02/05/21 Piper Sandler
- Piper reiterates Overweight on Kymera after Sanofi capital markets day
- 01/19/21 UBS
- Sanofi price target lowered to EUR 99 from EUR 100 at UBS
- 09:54 Today
- Fly Intel: Top five analyst upgrades
- 04:45 Today Jefferies
- AstraZeneca upgraded to Buy from Hold at Jefferies
- 03/09/21 Berenberg
- AstraZeneca price target lowered to 9,500 GBp from 10,000 GBp at Berenberg
- 03/08/21 Barclays
- AstraZeneca price target raised to 10,000 GBp from 9,000 GBp at Barclays
- 03/08/21 JPMorgan
- JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
- 03/03/21 H.C. Wainwright
- Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
- 02/12/21 Morgan Stanley
- GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley
- 02/11/21 Berenberg
- GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg
- 03/10/21
- Fly Intel: Top five analyst downgrades
- 03/10/21 Argus
- Novartis cut to Hold at Argus on slowing top-line growth, greater competition
- 03/10/21 Argus
- Novartis downgraded to Hold from Buy at Argus
- 03/01/21 Oppenheimer
- Homology Medicines loses potential source of upside, says Oppenheimer
- 05:24 Today Jefferies
- Roche downgraded to Hold on rising growth risks at Jefferies
- 03/15/21 Jefferies
- Roche downgraded to Hold from Buy at Jefferies
- 03/12/21 Jefferies
- Chugai Pharmaceutical downgraded to Hold from Buy at Jefferies
- 03/11/21 Evercore ISI
- Kodiak Sciences initiated with an Outperform at Evercore ISI
- 03/08/21 BofA
- Gartner added to US 1 List, Bristol-Myers removed at BofA
- 02/12/21 Morgan Stanley
- Amgen court decision may have readthrough for Gilead, says Morgan Stanley
- 02/02/21 BTIG
- Prothena upgraded to Buy at BTIG on birtamimab 'revival'
- 01/20/21 William Blair
- Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
- 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 01/25/21
- Notable companies reporting before tomorrow's open
- 01/29/21
- Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20
- 01/29/21
- Eli Lilly reports Q4 EPS $2.75, consensus $2.35
- 01/28/21
- Notable companies reporting before tomorrow's open
- 01/28/21
- Notable companies reporting before tomorrow's open
- 02/04/21
- Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41
- 02/04/21
- Merck reports Q4 adjusted EPS $1.32, consensus $1.38
- 02/03/21
- Notable companies reporting before tomorrow's open
- 02/03/21
- Notable companies reporting before tomorrow's open
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer reports Q4 adjusted EPS 42c, consensus 48c
- 02/01/21
- Notable companies reporting before tomorrow's open
- 02/05/21
- Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year
- 10/29/20
- Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year
- 02/11/21
- AstraZeneca sees FY21 core EPS $4.75-$5.00
- 02/11/21
- AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B
- 11/05/20
- AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage
- 11/05/20
- AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year
- 02/03/21
- GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago
- 10/28/20
- GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range
- 10/28/20
- GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago
- 10/08/20
- GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5%
- 01/26/21
- Novartis sees 2021 core operating income to grow mid single digit
- 01/26/21
- Novartis reports Q4 core EPS $1.34, consensus $1.36
- 11/05/20
- Xoma reports Q3 EPS (10c), consensus (21c)
- 10/27/20
- Novartis raises FY20 core operating income growth outlook
- 02/04/21
- Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year
- 10/27/20
- Oncolytics announces new GI cancer study using
- 10/15/20
- Roche confirms outlook for 2020 based on assessment of COVID-19
- 10/15/20
- Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year
- 03/04/21
- Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c)
- 02/24/21
- CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M
- 02/04/21
- Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45
- 02/04/21
- Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41
- 03/12/21
- France approves Johnson & Johnson's coronavirus vaccine, Reuters says
- 03/10/21
- Biden to announce U.S. buying 100M more doses of J&J vaccine, NBC reports
- 03/08/21
- Biden to meet with CEOs of J&J, Merck at White House, Reuters reports
- 03/05/21
- J&J COVID-19 vaccine approved by Canada's regulator, AP reports
- 02/10/21
- Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports
- 12/30/20
- Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 03/15/21
- Gilead, Merck to develop long-acting HIV therapy treatment, WSJ reports
- 03/10/21
- Biden to announce U.S. buying 100M more doses of J&J vaccine, NBC reports
- 03/08/21
- Biden to meet with CEOs of J&J, Merck at White House, Reuters reports
- 03/02/21
- Merck to help produce J&J Covid vaccine, Washington Post reports
- 03/15/21
- BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports
- 03/14/21
- EU Breton says Pfizer can help offset AstraZeneca vaccine delay, Reuters reports
- 03/10/21
- Pfizer wants to make vaccine in India if assured of fast clearance, Reuters says
- 03/09/21
- Terumo creates syringe to stretch Pfizer COVID vaccine supplies, Nikkei reports
- 03/15/21
- BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports
- 02/15/21
- CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports
- 02/15/21
- Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
- 02/11/21
- Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports
- 10:28 Today
- EMA says benefits of Astra's vaccine outweigh risks, WSJ reports
- 06:13 Today
- Italy suspends use of AstraZeneca vaccine, WSJ reports
- 03/15/21
- Astra's U.S. vaccine trial data under review by independent board, Reuters says
- 03/15/21
- Astra's U.S. vaccine trial data under review by independent board, Reuters says
- 02/09/21
- Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports
- 01/12/21
- GSK looks to double blockbusters in portfolio by 2026, Bloomberg says
- 12/31/20
- Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 03/15/21
- BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 02/11/21
- Roche arthritis drug reduced Covid deaths in study, Reuters reports
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 02/15/21
- Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
- 12/23/20
- Judge rules against White House drug pricing rule, Reuters says
- 11/23/20
- EU seeks easier access to generic medicines, Reuters says
- 11/20/20
- Trump to release new rules aimed at lowering drug prices, WSJ reports
- 03/11/21
- Fly Intel: Wall Street's top stories for Thursday
- 03/11/21
- Fly Intel: Wall Street's top stories at midday
- 03/10/21
- Fly Intel: Wall Street's top stories for Wednesday
- 03/10/21
- Fly Intel: Wall Street's top stories at midday
- 03/15/21
- Fly Intel: Wall Street's top stories for Monday
- 03/15/21
- Fly Intel: Wall Street's top stories at midday
- 03/15/21
- Fly Intel: Pre-market Movers
- 03/10/21
- Fly Intel: Wall Street's top stories for Wednesday
- 03/08/21
- Fly Intel: Wall Street's top stories for Monday
- 03/08/21
- Fly Intel: Wall Street's top stories at midday
- 03/02/21
- Fly Intel: Wall Street's top stories for Tuesday
- 03/02/21
- Fly Intel: Wall Street's top stories at midday
- 02/19/21
- Fly Intel: Wall Street's top stories for Friday
- 02/19/21
- Fly Intel: Wall Street's top stories at midday
- 02/18/21
- Fly Intel: Wall Street's top stories for Thursday
- 02/18/21
- Fly Intel: Wall Street's top stories at midday
- 02/22/21
- Fly Intel: Wall Street's top stories for Monday
- 02/22/21
- Fly Intel: Wall Street's top stories at midday
- 12/31/20
- Fly Intel: Wall Street's top stories for Thursday
- 12/26/20
- Week in review: How Trump's policies moved stocks
- 03/15/21
- Fly Intel: Wall Street's top stories for Monday
- 03/15/21
- Fly Intel: Wall Street's top stories at midday
- 03/11/21
- Fly Intel: Wall Street's top stories for Thursday
- 02/16/21
- Fly Intel: Wall Street's top stories for Tuesday
- 03/11/21
- Fly Intel: Wall Street's top stories for Thursday
- 03/11/21
- Fly Intel: Wall Street's top stories at midday
- 02/22/21
- Fly Intel: Wall Street's top stories for Monday
- 02/22/21
- Fly Intel: Wall Street's top stories at midday
- 03/10/21
- Novartis downgrade, HP Enterprise upgrade among today's top calls on Wall Street
- 02/11/21
- Fly Intel: Wall Street's top stories for Thursday
- 02/11/21
- Fly Intel: Wall Street's top stories at midday
- 02/11/21
- Fly Intel: Pre-market Movers
- 03/15/21
- Fly Intel: Wall Street's top stories for Monday
- 03/15/21
- Fly Intel: Wall Street's top stories at midday
- 03/15/21
- Fly Intel: Pre-market Movers
- 12/26/20
- Week in review: How Trump's policies moved stocks
- 02/09/21
- Fly Intel: Pre-market Movers
- 12/26/20
- Week in review: How Trump's policies moved stocks
- 11/21/20
- Week in review: How Trump's policies moved stocks
- 11/05/20
- Fly Intel: Pre-market Movers
- 03/01/21
- Unusually active option classes on open March 1st
- 01/26/21
- Early notable gainers among liquid option names on January 26th
- 12/01/20
- Johnson & Johnson call volume above normal and directionally bullish
- 10/13/20
- Unusually active option classes on open October 13th
- 03/11/21
- Eli Lilly call volume above normal and directionally bullish
- 03/10/21
- Eli Lilly call volume above normal and directionally bullish
- 01/15/21
- Eli Lilly call volume above normal and directionally bullish
- 01/13/21
- Early notable gainers among liquid option names on January 13th
- 03/02/21
- Unusually active option classes on open March 2nd
- 02/17/21
- Merck call volume above normal and directionally bullish
- 12/23/20
- Merck call volume above normal and directionally bullish
- 10/20/20
- Merck put volume heavy and directionally bearish
- 03/15/21
- Pfizer call volume above normal and directionally bullish
- 03/04/21
- Pfizer call volume above normal and directionally bullish
- 01/29/21
- Unusually active option classes on open January 29th
- 01/25/21
- Pfizer call volume above normal and directionally bullish
- 09:40 Today
- Unusually active option classes on open March 16th
- 02/24/21
- AstraZeneca call volume above normal and directionally bullish
- 02/17/21
- AstraZeneca call volume above normal and directionally bullish
- 12/30/20
- Unusually active option classes on open December 30th
- 01/20/21
- Unusually active option classes on open January 20th
- 01/11/21
- Unusually active option classes on open January 11th
- 01/05/21
- Bristol Myers Squibb call volume above normal and directionally bullish
- 01/04/21
- Bristol Myers Squibb call buyer realizes 25% same-day gains
|
|
Recommendations
| ShowHide Related Items >><< - 08:53 Today
- Ontrak appoints CVS Health's Chief Transformation Officer, Mayhew, as CEO
- 10/29/20
- Ontrak acquires behavior change platform LifeDojo
- 10/13/20
- Ontrak rises after announcing launch of Ontrak-CI program
- 10:29 Today
- Brookdale Senior Living completes second round of vaccine clinics at communities
- 08:53 Today
- Ontrak appoints CVS Health's Chief Transformation Officer, Mayhew, as CEO
- 08:12 Today
- CVS Health: COVID-19 antibody testing available at all MinuteClinics in Texas
- 08:10 Today
- CVS Health: COVID-19 antibody testing available at all MinuteClinics in MA
- 03/02/21 B. Riley Securities
- Ontrak price target lowered to $73 from $110 at B. Riley Securities
- 03/02/21 Cowen
- Cowen downgrades Ontrak to Market Perform until visibility returns
- 03/02/21 Canaccord
- Canaccord downgrades Ontrak after loss of largest customer
- 03/02/21 Cowen
- Ontrak downgraded to Market Perform from Outperform at Cowen
- 09:26 Today Morgan Stanley
- Higher vaccine reimbursement a 'windfall' for pharmacies, says Morgan Stanley
- 03/02/21 Cowen
- Cowen downgrades Ontrak to Market Perform until visibility returns
- 03/02/21 Canaccord
- Canaccord downgrades Ontrak after loss of largest customer
- 03/01/21 RBC Capital
- RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
- 03/09/21
- Ontrak sees FY21 revenue $100M, consensus $97.07M
- 03/09/21
- Ontrak reports Q4 adjusted EPS (7c), consensus (39c)
- 03/01/21
- Ontrak sees FY21 revenue $100M, consensus $165.05M
- 03/01/21
- Ontrak reports Q4 EPS (7c), consensus (30c)
- 02/16/21
- CVS Health sees FY21 revenue $276.1B-$280.6B, consensus $278.39B
- 02/16/21
- CVS Health sees FY21 adjusted EPS $7.39-$7.55, consensus $7.54
- 02/16/21
- CVS Health reports Q4 adjusted EPS $1.30, consensus $1.24
- 11/06/20
- CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27
- 03/02/21
- IPG Mediabrands planning event focused on Black-owned media firms, AdAge says
- 02/14/21
- Walmart COVID vaccine rollout heading to small towns, WSJ reports
- 02/11/21
- CVS, Walmart to decide who gets leftover vaccine doses, WSJ reports
- 01/02/21
- Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says
- 03/10/21
- Fly Intel: Pre-market Movers
- 03/09/21
- Fly Intel: After-Hours Movers
- 03/01/21
- Fly Intel: Wall Street's top stories for Monday
- 03/01/21
- Fly Intel: Wall Street's top stories at midday
- 03/01/21
- Ontrak plunges after announcing loss of Aetna contract
- 02/16/21
- Fly Intel: Wall Street's top stories at midday
- 02/16/21
- Fly Intel: Pre-market Movers
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
- 10/12/20
- Largest borrow rate increases among liquid names
- 09/16/20
- Ontrak put volume heavy and directionally bearish
- 02/16/21
- Unusually active option classes on open February 16th
- 01/11/21
- CVS Health call volume above normal and directionally bullish
- 11/17/20
- Unusually active option classes on open November 17th
- 11/10/20
- CVS Health call volume above normal and directionally bullish
|
|
Hot Stocks
| ShowHide Related Items >><< BKD Brookdale Senior Living - 03/15/21
- California AG sues Brookdale Senior Living, alleges false info given to CMS
- 03/08/21
- Brookdale Senior Living announces occupancy for February
- 02/25/21
- Brookdale Senior Living rises 23.4%
- 02/24/21
- Brookdale Senior Living sees FY21 non-development CapEx approximately $140M
- 08:53 Today
- Ontrak appoints CVS Health's Chief Transformation Officer, Mayhew, as CEO
- 08:12 Today
- CVS Health: COVID-19 antibody testing available at all MinuteClinics in Texas
- 08:10 Today
- CVS Health: COVID-19 antibody testing available at all MinuteClinics in MA
- 03/11/21
- CVS Health now offering COVID-19 vaccines in 29 States
BKD Brookdale Senior Living - 03/09/21 RBC Capital
- Brookdale Senior Living price target raised to $7 from $4 at RBC Capital
- 01/11/21 BMO Capital
- Brookdale data supports cautious view on senior housing, says BMO
- 12/02/20 Jefferies
- Brookdale Senior Living downgraded to Hold following run-up at Jefferies
- 12/02/20 Jefferies
- Brookdale Senior Living downgraded to Hold from Buy at Jefferies
- 09:26 Today Morgan Stanley
- Higher vaccine reimbursement a 'windfall' for pharmacies, says Morgan Stanley
- 03/02/21 Cowen
- Cowen downgrades Ontrak to Market Perform until visibility returns
- 03/02/21 Canaccord
- Canaccord downgrades Ontrak after loss of largest customer
- 03/01/21 RBC Capital
- RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
BKD Brookdale Senior Living - 02/24/21
- Brookdale Senior Living reports Q4 EPS (24c), consensus (15c)
- 11/04/20
- Brookdale Senior Living reports Q3 EPS (68c), consensus (28c)
- 02/16/21
- CVS Health sees FY21 revenue $276.1B-$280.6B, consensus $278.39B
- 02/16/21
- CVS Health sees FY21 adjusted EPS $7.39-$7.55, consensus $7.54
- 02/16/21
- CVS Health reports Q4 adjusted EPS $1.30, consensus $1.24
- 11/06/20
- CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27
- 03/02/21
- IPG Mediabrands planning event focused on Black-owned media firms, AdAge says
- 02/14/21
- Walmart COVID vaccine rollout heading to small towns, WSJ reports
- 02/11/21
- CVS, Walmart to decide who gets leftover vaccine doses, WSJ reports
- 01/02/21
- Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says
- 03/01/21
- Ontrak plunges after announcing loss of Aetna contract
- 02/16/21
- Fly Intel: Wall Street's top stories at midday
- 02/16/21
- Fly Intel: Pre-market Movers
- 12/01/20
- Fly Intel: What to watch in Salesforce's earnings report
BKD Brookdale Senior Living - 11/04/20
- Brookdale Senior Living options imply 23.5% move in share price post-earnings
- 02/16/21
- Unusually active option classes on open February 16th
- 01/11/21
- CVS Health call volume above normal and directionally bullish
- 11/17/20
- Unusually active option classes on open November 17th
- 11/10/20
- CVS Health call volume above normal and directionally bullish
|